“We treated successfully many hundreds of the hi
Post# of 148167
(Total Views: 873)
Posted On: 01/26/2021 5:41:22 AM
Re: Rubraquercus #74390
“We treated successfully many hundreds of the high risk and symptomatic patients,” Dr. Fareed testified, noting that he uses a triple HCQ cocktail: HCQ (3200 mg over 5 days), ivermectin, azithromycin or doxycycline and zinc aimed at disrupting viral replication.
Vitamins C and D as well as Quercetin, anti-coagulants and corticosteroids such as dexamethasone and prednisone further “reduce the risk of escalation to cytokine storm and blood-clotting,” he said.
“The multi-drug cocktail is best given early within the first 5 to 7 days while the patient is in the flu stage. I use it especially in high risk individuals, anyone over 60 or with co-morbidities, and anyone with moderate to severe flu symptoms,” Dr. Fareed explained.
“I used this regimen to successfully treat 31 elderly nursing home residents in an outbreak in June. 29 recovered fully,” he added.
“The science tells us that early treatment would be an effective strategy to use on a national level,” Farred said. “This realization motivated me and a few of my colleagues to write a letter to the President, a letter to my congressman, a letter to California health department, an Open Letter to Dr. Fauci, and a National Plan for Covid-19.
“As we describe in the National Plan, this approach would be the solution to the pandemic; protect the vulnerable, and if high risk individuals get sick, there is a solution for them as well—early treatment with the antiviral cocktail.”
It bears noting that HCQ has not been included in the NIH’s “upgrades” on Covid treatments although it continues to be re-purposed as a frontline Covid treatment in many parts of the world.
Despite voluminous evidence of its safety and efficacy by leading experts, including FLCCC physicians at the May and November Senate hearings, government health agencies have consistently blocked the drug’s release from national stockpiles.
Delaying Treatment Can Be Disastrous
“This is a very insidious disease and as we’ve seen, it can progress to deadly levels with no explanation,” Dr. Peter McCullough of Baylor University Medical Center Hospital in Dallas, stressed at the Senate hearing. “The idea of not treating it until a patient gets to the hospital does not make sense.”
“Unlike the flu or viruses that caused previous pandemics, Covid-19 can lead to three distinct, lethal outcomes: viral damage to organs, cytokine storm, and micro-thrombosis (blood clots). The mortality curve can reach 30 days [after infection],” Dr. McCullough noted.
“Patients wait in fear at home after testing positive, logically thinking they would face a terrifying hospitalization, isolation, and at worse–death. But delayed treatment for many can be disastrous. Early home treatment is the answer. The hospital should only be a safety net for survival. It should not be the first place of treatment.”
“The United States would be wise to follow what India and Brazil have done and make available at-home Covid-19 treatment kits containing dosages of ivermectin, HCQ and key vitamin supplements,” Dr. McCullough urged. “Why should someone getting infected in the United States have a greater chance of dying from the disease, than a citizen of poorer countries who has access to early treatment?”
McCullough urged the Senate committee “to ask all responsible government agencies to prioritize an early treatment initiative. Competent physicians should be supported by all stakeholders in their efforts to provide patients with compassionate care, reduce the spread of infection, and avoid hospitalization and death,” he said.
“I believe this is the only viable strategy to avoid catastrophic loss of life before natural immunity and vaccination can bring this crisis to a close,” he concluded.
‘The Virus is Easy to Kill’
Renowned gastroenterologist Dr. Thomas Borody, medical director of Australia’s Center for Digestive Disease, was one of the first experts calling for ivermectin to be used for Covid treatment as early as last August.
Borody who is credited with developing a triple therapy that eradicates peptic ulcers once thought to be incurable, has joined forces with California researcher Dr. Sabine Hazan, founder of Ventura Clinical Trials, to create a protocol for Covid treatment.
“Studies on ivermectin show amazing success–clear and statistically significant benefits for pre-exposure and post-exposure prophylaxis, as well as effectively reducing mortality in early and late disease phases,” Barody said in a televised interview on Sky News.
“The virus is surprisingly easy to kill,” he said.
Borody said an ivermectin tablet could cost as little as $2, which is likely why drug makers haven’t promoted the drug’s usage. He also suggested that having a relatively easy way to wipe out the disease would drastically reduce hospitalizations which in turn would sharply cut industry profits. Not everyone is going to be happy about that, which is perhaps why the establishment continues to ignore outpatient Covid remedies.
Doctors can’t get government health agencies to even look at the medical data, Dr. Borody said, noting that his effort to alert his own government to the “powerful activity of ivermectin against the virus on the intercellular level” was met with silence.
“Neither the United States or Australia have a curative program for Covid-19. It’s all about lockdowns and vaccines,” he said. The vaccine has benefits but as its proponents admit, “it does not cure the disease or prevent its transmission. Ivermectin does both.”
Some have noted that the vaccine was issued with an Emergency Use Authorization (EUA), which falls short of full FDA approval as its long-term safety has not yet been assured. According to the law, the EUA remains valid only as long as no other safe, effective medical alternative exists.
Could Ivermectin’s potential success in eradicating Covid be seen as reducing the need for a vaccine, Dr. Borody was asked in an interview. He dismissed this notion, saying both options are vital. “The guiding principle is to use all available means to save lives now. To end the pandemic we must treat and vaccinate, treat and vaccinate.”
Vitamins C and D as well as Quercetin, anti-coagulants and corticosteroids such as dexamethasone and prednisone further “reduce the risk of escalation to cytokine storm and blood-clotting,” he said.
“The multi-drug cocktail is best given early within the first 5 to 7 days while the patient is in the flu stage. I use it especially in high risk individuals, anyone over 60 or with co-morbidities, and anyone with moderate to severe flu symptoms,” Dr. Fareed explained.
“I used this regimen to successfully treat 31 elderly nursing home residents in an outbreak in June. 29 recovered fully,” he added.
“The science tells us that early treatment would be an effective strategy to use on a national level,” Farred said. “This realization motivated me and a few of my colleagues to write a letter to the President, a letter to my congressman, a letter to California health department, an Open Letter to Dr. Fauci, and a National Plan for Covid-19.
“As we describe in the National Plan, this approach would be the solution to the pandemic; protect the vulnerable, and if high risk individuals get sick, there is a solution for them as well—early treatment with the antiviral cocktail.”
It bears noting that HCQ has not been included in the NIH’s “upgrades” on Covid treatments although it continues to be re-purposed as a frontline Covid treatment in many parts of the world.
Despite voluminous evidence of its safety and efficacy by leading experts, including FLCCC physicians at the May and November Senate hearings, government health agencies have consistently blocked the drug’s release from national stockpiles.
Delaying Treatment Can Be Disastrous
“This is a very insidious disease and as we’ve seen, it can progress to deadly levels with no explanation,” Dr. Peter McCullough of Baylor University Medical Center Hospital in Dallas, stressed at the Senate hearing. “The idea of not treating it until a patient gets to the hospital does not make sense.”
“Unlike the flu or viruses that caused previous pandemics, Covid-19 can lead to three distinct, lethal outcomes: viral damage to organs, cytokine storm, and micro-thrombosis (blood clots). The mortality curve can reach 30 days [after infection],” Dr. McCullough noted.
“Patients wait in fear at home after testing positive, logically thinking they would face a terrifying hospitalization, isolation, and at worse–death. But delayed treatment for many can be disastrous. Early home treatment is the answer. The hospital should only be a safety net for survival. It should not be the first place of treatment.”
“The United States would be wise to follow what India and Brazil have done and make available at-home Covid-19 treatment kits containing dosages of ivermectin, HCQ and key vitamin supplements,” Dr. McCullough urged. “Why should someone getting infected in the United States have a greater chance of dying from the disease, than a citizen of poorer countries who has access to early treatment?”
McCullough urged the Senate committee “to ask all responsible government agencies to prioritize an early treatment initiative. Competent physicians should be supported by all stakeholders in their efforts to provide patients with compassionate care, reduce the spread of infection, and avoid hospitalization and death,” he said.
“I believe this is the only viable strategy to avoid catastrophic loss of life before natural immunity and vaccination can bring this crisis to a close,” he concluded.
‘The Virus is Easy to Kill’
Renowned gastroenterologist Dr. Thomas Borody, medical director of Australia’s Center for Digestive Disease, was one of the first experts calling for ivermectin to be used for Covid treatment as early as last August.
Borody who is credited with developing a triple therapy that eradicates peptic ulcers once thought to be incurable, has joined forces with California researcher Dr. Sabine Hazan, founder of Ventura Clinical Trials, to create a protocol for Covid treatment.
“Studies on ivermectin show amazing success–clear and statistically significant benefits for pre-exposure and post-exposure prophylaxis, as well as effectively reducing mortality in early and late disease phases,” Barody said in a televised interview on Sky News.
“The virus is surprisingly easy to kill,” he said.
Borody said an ivermectin tablet could cost as little as $2, which is likely why drug makers haven’t promoted the drug’s usage. He also suggested that having a relatively easy way to wipe out the disease would drastically reduce hospitalizations which in turn would sharply cut industry profits. Not everyone is going to be happy about that, which is perhaps why the establishment continues to ignore outpatient Covid remedies.
Doctors can’t get government health agencies to even look at the medical data, Dr. Borody said, noting that his effort to alert his own government to the “powerful activity of ivermectin against the virus on the intercellular level” was met with silence.
“Neither the United States or Australia have a curative program for Covid-19. It’s all about lockdowns and vaccines,” he said. The vaccine has benefits but as its proponents admit, “it does not cure the disease or prevent its transmission. Ivermectin does both.”
Some have noted that the vaccine was issued with an Emergency Use Authorization (EUA), which falls short of full FDA approval as its long-term safety has not yet been assured. According to the law, the EUA remains valid only as long as no other safe, effective medical alternative exists.
Could Ivermectin’s potential success in eradicating Covid be seen as reducing the need for a vaccine, Dr. Borody was asked in an interview. He dismissed this notion, saying both options are vital. “The guiding principle is to use all available means to save lives now. To end the pandemic we must treat and vaccinate, treat and vaccinate.”
(5)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼